Audience Switcher Modal

Counter Joe
Counter Grandma portions
Counter Mom
Counter Helping Hands
Counter Grandma treats
Bayer logo Bayer logo Bayer logo
Xarelto logo

Xarelto®
Protect what matters most for your cardiovascular patients

Resources hub

XareltoTube

XareltoTUBE XareltoTUBE

Short videos and tools to illustrate the science behind thrombotic events as well as the benefits.

Major Studies

major-studies major-studies

Clinical Studies – Targeting Acute and Chronic Thromboembolic Disorders.

Xarelto 20 mg

major-studies major-studies

View the data that helped Xarelto to become the most broadly indicated novel OAC in the world.

Treatment Information

Dosing Guide

Important information about Xarelto initiation and dosing.
Practical Management

Ensure patients receive the most appropriate anticoagulant therapy suited to their needs.
Prescribing Information

Explore the Xarelto Summary of Product Characteristics.

RELATED PODCAST

 

 

PP-XAR-ALL-1786-2

References

© 2022 Bayer AG

This website contains information on Xarelto (rivaroxaban) which is based on the Summary of Product Characteristics (SPC) as approved by the European Commission. It is intended to provide information to an international audience outside the USA and UK.

Last updated on September 2022